Jiangxi Synergy Pharmaceutical Co., Ltd.

SZSE:300636 Stock Report

Market Cap: CN¥3.6b

Jiangxi Synergy Pharmaceutical Future Growth

Future criteria checks 5/6

Jiangxi Synergy Pharmaceutical is forecast to grow earnings and revenue by 33.8% and 23.2% per annum respectively. EPS is expected to grow by 32.2% per annum. Return on equity is forecast to be 8.3% in 3 years.

Key information

33.8%

Earnings growth rate

32.2%

EPS growth rate

Pharmaceuticals earnings growth18.4%
Revenue growth rate23.2%
Future return on equity8.3%
Analyst coverage

Low

Last updated18 Jul 2024

Recent future growth updates

No updates

Recent updates

Is Jiangxi Synergy Pharmaceutical (SZSE:300636) A Risky Investment?

Jun 28
Is Jiangxi Synergy Pharmaceutical (SZSE:300636) A Risky Investment?

Jiangxi Synergy Pharmaceutical's (SZSE:300636) Profits Appear To Have Quality Issues

May 01
Jiangxi Synergy Pharmaceutical's (SZSE:300636) Profits Appear To Have Quality Issues

Jiangxi Synergy Pharmaceutical Co., Ltd.'s (SZSE:300636) 41% Share Price Surge Not Quite Adding Up

Apr 27
Jiangxi Synergy Pharmaceutical Co., Ltd.'s (SZSE:300636) 41% Share Price Surge Not Quite Adding Up

Earnings and Revenue Growth Forecasts

SZSE:300636 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,361320N/A5121
12/31/20251,141212N/A2922
12/31/2024907169N/A4011
3/31/2024708116-40108N/A
12/31/2023722106-51164N/A
9/30/2023751105-70160N/A
6/30/2023766115-51211N/A
3/31/2023761107-114185N/A
1/1/2023720101-115196N/A
9/30/202269289-171172N/A
6/30/202265181-189193N/A
3/31/202263588-219206N/A
12/31/202159281-293131N/A
9/30/202152476-312109N/A
6/30/202147671-29073N/A
3/31/202147674-22689N/A
12/31/202043570-15080N/A
9/30/202047167-12454N/A
6/30/202045563-12823N/A
3/31/202042860-1394N/A
12/31/201941348-213-28N/A
9/30/201936140-1895N/A
6/30/201933632-19533N/A
3/31/201927723-20737N/A
12/31/201826725-16775N/A
9/30/201826239-17969N/A
6/30/201827051-11795N/A
3/31/201830358-10558N/A
12/31/201729765N/A34N/A
9/30/201729875N/A52N/A
6/30/201728265N/A26N/A
3/31/201725757N/A28N/A
12/31/201625058N/A60N/A
9/30/201624852N/A57N/A
6/30/201626861N/A69N/A
3/31/201626963N/A90N/A
12/31/201527563N/A79N/A
12/31/201421339N/A65N/A
12/31/201314217N/A14N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300636's forecast earnings growth (33.8% per year) is above the savings rate (2.9%).

Earnings vs Market: 300636's earnings (33.8% per year) are forecast to grow faster than the CN market (22.1% per year).

High Growth Earnings: 300636's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300636's revenue (23.2% per year) is forecast to grow faster than the CN market (13.5% per year).

High Growth Revenue: 300636's revenue (23.2% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 300636's Return on Equity is forecast to be low in 3 years time (8.3%).


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.